| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |